Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Vigil Neuroscience, Inc. | 75,500 | reported | 01 Mar 2022 | tx 1+75,500 |
| Adamas Pharmaceuticals Inc | 0 | reported | 24 Nov 2021 | tx 8+50,975−50,975 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Mar 2022 | GRANT_AWARD | Vigil Neuroscience, Inc. | 75,500 | 0.00 USD | deriv |
| 24 Nov 2021 | TENDER | Adamas Pharmaceuticals Inc | 20,975 | — | |
| 24 Nov 2021 | OTHER | Adamas Pharmaceuticals Inc | 20,000 | — | deriv |
| 24 Nov 2021 | OTHER | Adamas Pharmaceuticals Inc | 10,000 | — | deriv |
| 02 Jun 2021 | GRANT_AWARD | Adamas Pharmaceuticals Inc | 5,000 | 0.00 USD | |
| 02 Jun 2021 | GRANT_AWARD | Adamas Pharmaceuticals Inc | 10,000 | 0.00 USD | deriv |
| 11 Mar 2021 | PURCHASE | Adamas Pharmaceuticals Inc | 5,975 | 5.06 USD | |
| 22 Nov 2020 | GRANT_AWARD | Adamas Pharmaceuticals Inc | 10,000 | 0.00 USD | |
| 22 Nov 2020 | GRANT_AWARD | Adamas Pharmaceuticals Inc | 20,000 | 0.00 USD | deriv |